Overview

Fecal Microbiota Transplant (FMT) in Melanoma Patients

Status:
Active, not recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The main goal of this research study is to determine if the fecal microbiota transplant (FMT) improves the body's ability to fight your cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Zarour, Hassane, MD
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Pembrolizumab